Structural Analysis of Inhibitor Binding to Enterovirus-D68 3C Protease
Enterovirus-D68 (EV68) continues to present as a global health issue causing respiratory illness and outbreaks associated with long-lasting neurological disease, with no antivirals or specific treatment options. The development of antiviral therapeutics, such as small-molecule inhibitors that target...
Saved in:
Main Authors: | Vincent N. Azzolino, Ala M. Shaqra, Akbar Ali, Nese Kurt Yilmaz, Celia A. Schiffer |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/17/1/75 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pretreatment with serine protease inhibitors impairs Leishmania amazonensis survival on macrophages
by: Patrícia de Almeida Machado, et al.
Published: (2025-01-01) -
Completely conserved VP2 residue K140 of KREMEN1-dependent enteroviruses is critical for virus-receptor interactions and viral infection
by: Zeyu Liu, et al.
Published: (2025-02-01) -
A nucleoside-modified mRNA vaccine prevents enterovirus A71 infection in mouse model
by: Fengyu Chi, et al.
Published: (2025-02-01) -
Bicyclic peptide-enhanced covalent inhibitor of SARS-CoV-2 3CL protease
by: Qian Wang, et al.
Published: (2024-10-01) -
Adverse events following immunization surveillance on two types of enterovirus 71 vaccines: A real-world comparative study in China
by: Yiqing Zhu, et al.
Published: (2025-12-01)